Register to chat with like-minded investors on our interactive forums.
Period:
Draw Mode:
| Volume | 68,178 |
|
|||||
| News | - | ||||||
| Day High | 3.66 | Low High |
|||||
| Day Low | 3.48 | ||||||
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Generation Bio Company | GBIO | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded
|
|
|---|---|---|---|---|
| -0.19 | -5.11% | 3.53 | 12:43:38 |
| Open Price | Low Price | High Price | Close Price | Prev Close |
|---|---|---|---|---|
| 3.62 | 3.48 | 3.66 | 3.72 |
| Trades | Volume | VWAP | Dollar Volume | Avg Volume | 52 Week Range |
|---|---|---|---|---|---|
| 768 | 68,178 | $ 3.57 | $ 243,163 | - | 0.86 - 6.98 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 12:47:12 | 4 | $ 3.52 | USD |
Generation Bio Company Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| 234.66M | 66.48M | - | 5.9M | -126.61M | -1.90 | - |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | - | - | - |
Generation Bio News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical GBIO Price Data
| Period | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 4.35 | 4.52 | 3.415 | 3.81 | 171,874 | -0.82 | -18.85% |
| 1 Month | 2.96 | 4.65 | 2.81 | 3.84 | 241,069 | 0.57 | 19.26% |
| 3 Months | 1.83 | 4.65 | 1.73 | 2.87 | 245,212 | 1.70 | 92.90% |
| 6 Months | 3.10 | 4.65 | 0.86 | 1.74 | 570,799 | 0.43 | 13.87% |
| 1 Year | 4.45 | 6.98 | 0.86 | 2.33 | 359,087 | -0.92 | -20.67% |
| 3 Years | 27.99 | 38.86 | 0.86 | 8.28 | 362,989 | -24.46 | -87.39% |
| 5 Years | 22.15 | 55.72 | 0.86 | 13.04 | 363,205 | -18.62 | -84.06% |
Generation Bio Description
| Generation Bio Co is a genetics medicine company that is focused on creating gene therapies to provide durable and redosable treatments for patients suffering from rare and untreated diseases. The company focuses on liver and retina related diseases. |
